FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jaime Caro

Research Profile

Activities & Behaviors

Concepts & Ideas

Geographic Areas

Procedures

Disorders

Chemicals & Drugs

Antihypertensive Agents

Co-author Network

Publications

TOP 3
Jersey Chen; Chunxue Shi; Elizabeth M Mahoney; Elizabeth Schneider Dunn; Stéphane Rinfret; Jaime Caro; Judith O'Brien; Wissam El-Hadi; Deepak L Bhatt; Eric J Topol; David J Cohen
Economic evaluation of clopidogrel plus aspirin for secondary prevention of cardiovascular events in Canada for patients with established cardiovascular disease: Results from the CHARISMA trial.
Jersey Chen; Deepak L Bhatt; Elizabeth Schneider Dunn; Chunxue Shi; Jaime Caro; Elizabeth M Mahoney; Sylvie Gabriel; Joseph D Jackson; Eric J Topol; David J Cohen
Cost-effectiveness of clopidogrel plus aspirin versus aspirin alone for secondary prevention of cardiovascular events: results from the CHARISMA trial.
Thitima Kongnakorn; Alexandra Ward; Craig S Roberts; Judith A O'Brien; Irina Proskorovsky; Jaime Caro
Economic evaluation of atorvastatin for prevention of recurrent stroke based on the SPARCL trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jaime Caro (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Jersey Chen; Chunxue Shi; Elizabeth M Mahoney; Elizabeth Schneider Dunn; Stéphane Rinfret; Jaime Caro; Judith O'Brien; Wissam El-Hadi; Deepak L Bhatt; Eric J Topol; David J Cohen
Economic evaluation of clopidogrel plus aspirin for secondary prevention of cardiovascular events in Canada for patients with established cardiovascular disease: Results from the CHARISMA trial.
The Canadian journal of cardiology 2011;27(2):222-31.
2009: Jersey Chen; Deepak L Bhatt; Elizabeth Schneider Dunn; Chunxue Shi; Jaime Caro; Elizabeth M Mahoney; Sylvie Gabriel; Joseph D Jackson; Eric J Topol; David J Cohen
Cost-effectiveness of clopidogrel plus aspirin versus aspirin alone for secondary prevention of cardiovascular events: results from the CHARISMA trial.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2009;12(6):872-9.
2009: Thitima Kongnakorn; Alexandra Ward; Craig S Roberts; Judith A O'Brien; Irina Proskorovsky; Jaime Caro
Economic evaluation of atorvastatin for prevention of recurrent stroke based on the SPARCL trial.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2009;12(6):880-7.
2009: Jaime Caro; Krista F Huybrechts
Case-control studies in pharmacoeconomic research: an overview.
PharmacoEconomics 2009;27(8):627-34.
2009: Krista F Huybrechts; Jaime Caro; Judith A O'Brien
Prevention and management of hyperphosphatemia with sevelamer in Canada: health and economic consequences.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2009;12(1):16-9.
2008: K A Payne; Jaime Caro; W L Daley; Z M Khan; K J Ishak; K Stark; D Purkayastha; John M Flack; E Velázquez; S Nesbitt; D Morisky; Robert M Califf
The design of an observational study of hypertension management, adherence and pressure control in Blood Pressure Success Zone Program participants.
International journal of clinical practice 2008;62(9):1313-21.
2008: K Jack Ishak; Ye Tan; Jennifer Glass; Doanh Luong; Jaime Caro
Risk of discontinuation of risperidone after exposure to potentially interacting drugs: a nested case-control study in patients with schizophrenia.
Clinical therapeutics 2008;30(7):1251-63.
2008: Krista F Huybrechts; Jaime Caro; James J Xenakis; Konstantinos N Vemmos
The prognostic value of the modified Rankin Scale score for long-term survival after first-ever stroke. Results from the Athens Stroke Registry.
Cerebrovascular diseases (Basel, Switzerland) 2008;26(4):381-7.
2008: Baris Deniz; Jaime Caro; Alexandra Ward; Jorgen Moller; Farzana Malik
Economic and health consequences of managing bradycardia with dual-chamber compared to single-chamber ventricular pacemakers in Italy.
Journal of cardiovascular medicine (Hagerstown, Md.) 2008;9(1):43-50.
2007: Judith A O'Brien; Betsy J Lahue; Jaime Caro; David Davidson
The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2007;28(11):1219-27.
2007: Krista A Payne; Marie-Pierre Desrosiers; Jaime Caro; Jean-Francois Baladi; Noreen Lordan; Irina Proskorovsky; Khajak J Ishak; Diana Rofail
Clinical and economic burden of infused iron chelation therapy in the United States.
Transfusion 2007;47(10):1820-9.
2007: Alexandra Ward; Duygu Bozkaya; Jochen Fleischmann; Dominique Dubois; Rainer Sabatowski; Jaime Caro
Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone.
Current medical research and opinion 2007;23(10):2333-45.
2007: Joseph Jackson; Jaime Caro; Graciela Caro; Frances Garfield; Ferdinand Huber; Wenjiong Zhou; Chen-Sheng Lin; Douglas Shander; Kathy Schrode
The effect of eflornithine 13.9% cream on the bother and discomfort due to hirsutism.
International journal of dermatology 2007;46(9):976-81.
2007: Jack Ansell; Jaime Caro; Maribel Salas; Rowena J Dolor; William Corbett; Andrew Hudnut; Saleem Seyal; Noreen D Lordan; Irina Proskorovsky; Gail Wygant
Quality of clinical documentation and anticoagulation control in patients with chronic nonvalvular atrial fibrillation in routine medical care.
American journal of medical quality : the official journal of the American College of Medical Quality 2007;22(5):327-33.
2007: Jaime Caro; Denis Getsios; Jörgen Möller
Regarding probabilistic analysis and computationally expensive models: necessary and required?
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2007;10(4):317-8; author reply 319.
2007: Krista F Huybrechts; Jaime Caro
The Barthel Index and modified Rankin Scale as prognostic tools for long-term outcomes after stroke: a qualitative review of the literature.
Current medical research and opinion 2007;23(7):1627-36.
2007: Denis Getsios; Kristen Migliaccio-Walle; Jaime Caro
NICE cost-effectiveness appraisal of cholinesterase inhibitors: was the right question posed? Were the best tools used?
PharmacoEconomics 2007;25(12):997-1006.
2007: Khajak J Ishak; Robert W Platt; Lawrence Joseph; James A Hanley; Jaime Caro
Meta-analysis of longitudinal studies.
Clinical trials (London, England) 2007;4(5):525-39.
2007: Jaime Caro; Jörgen Möller; Denis Getsios; Laurent Coudeville; Wissam El-Hadi; Catherine Chevat; Van Hung Nguyen; Ingrid Caro
Invasive meningococcal disease epidemiology and control measures: a framework for evaluation.
BMC public health 2007;7():130.
2007: Jaime Caro; Alexandra Ward; Baris Deniz; Judith A O'Brien; Jenifer L Ehreth
Cost-benefit analysis of preventing sudden cardiac deaths with an implantable cardioverter defibrillator versus amiodarone.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2007;10(1):13-22.
2006: Jaime Caro; Krista F Huybrechts; James G Xenakis; Judith A O'Brien; Krithika Rajagopalan; Karen Lee
Budgetary impact of treating acute bipolar mania in hospitalized patients with quetiapine: an economic analysis of clinical trials.
Current medical research and opinion 2006;22(11):2233-42.
2006: Jaime Caro; James G Xenakis; Krista F Huybrechts
Ignoring study design heterogeneity in meta-analyses.
Archives of internal medicine 2006;166(18):2046; author reply 2046-7.
2006: Kristen Migliaccio-Walle; Jaime Caro; Jörgen Möller
Economic implications of growth hormone use in patients with short bowel syndrome.
Current medical research and opinion 2006;22(10):2055-63.
2006: Alexandra Ward; Shien Guo; Jaime Caro
Cost-effectiveness of cardiac resynchronization therapy.
Journal of the American College of Cardiology 2006;48(6):1283.
2006: Judith A O'Brien; Jaime Caro; Denis Getsios
Managing meningococcal disease in the United States: Hospital case characteristics and costs by age.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2006;9(4):236-43.
2006: Jaime Caro; Shien Guo; Alexandra Ward; Shajil Chalil; Farzana Malik; Francisco Leyva
Modelling the economic and health consequences of cardiac resynchronization therapy in the UK.
Current medical research and opinion 2006;22(6):1171-9.
2006: Michael T Halpern; Zeba M Khan; Jordana K Schmier; Michel Burnier; Jaime Caro; Joyce A Cramer; William L Daley; Jerry Gurwitz; Norman K Hollenberg
Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data.
Hypertension 2006;47(6):1039-48.
2006: Krista F Huybrechts; Khajak J Ishak; Jaime Caro
Assessment of compliance with osteoporosis treatment and its consequences in a managed care population.
Bone 2006;38(6):922-8.
2006: Maurice McGregor; Jaime Caro
QALYs: are they helpful to decision makers?
PharmacoEconomics 2006;24(10):947-52.
2006: Jaime Caro; Kristen Migliaccio-Walle; Khajak J Ishak; Irina Proskorovsky; Judith A O'Brien
The time course of subsequent hospitalizations and associated costs in survivors of an ischemic stroke in Canada.
BMC health services research 2006;6():99.
2005: Jaime Caro; Kristen Migliaccio-Walle; Judith A O'Brien; William Nova; Jennifer Kim; Ole Hauch; Eric Hillson; Hans Wedel; Ake Hjalmarson; Stephen S Gottlieb; Prakash C Deedwania; John Wikstrand
Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial.
Journal of cardiac failure 2005;11(9):647-56.
2005: Krista F Huybrechts; Jaime Caro; David A Wilson; Judith A O'Brien
Health and economic consequences of sevelamer use for hyperphosphatemia in patients on hemodialysis.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2005;8(5):549-61.
2005: Jaime Caro; Denis Getsios; Wissam El-Hadi; Krista Payne; Judith A O'Brien
Pertussis immunization of adolescents in the United States: an economic evaluation.
The Pediatric infectious disease journal 2005;24(5 Suppl):S75-82.
2005: Kevin D Forsyth; Tina Tan; Carl-Heinz Wirsing von König; Jaime Caro; Stanley Plotkin
Potential strategies to reduce the burden of pertussis.
The Pediatric infectious disease journal 2005;24(5 Suppl):S69-74.
2005: David P Greenberg; Jaime Caro
Summary: health and economic burden of pertussis.
The Pediatric infectious disease journal 2005;24(5 Suppl):S55-7.
2005: Jaime Caro; Denis Getsios; Krista Payne; Lieven Annemans; Peter J Neumann; evelinda trindade
Economic burden of pertussis and the impact of immunization.
The Pediatric infectious disease journal 2005;24(5 Suppl):S48-54.
2005: A Ward; Krista A Payne; Jaime Caro; Peter U Heuschmann; Peter L Kolominsky-Rabas
Care needs and economic consequences after acute ischemic stroke: the Erlangen Stroke Project.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2005;12(4):264-7.
2005: Krista F Huybrechts; Jaime Caro; Gérard M London
Modeling the implications of changes in vascular calcification in patients on hemodialysis.
Kidney international 2005;67(4):1532-8.
2005: Denis Getsios; Wissam El-Hadi; Ingrid Caro; Jaime Caro
Pharmacological management of overactive bladder : a systematic and critical review of published economic evaluations.
PharmacoEconomics 2005;23(10):995-1006.
2005: Judith A O'Brien; Jaime Caro
Hospitalization for pertussis: profiles and case costs by age.
BMC infectious diseases 2005;5():57.
2005: Kristen Migliaccio-Walle; Jaime Caro; Khajak J Ishak; Judith A O'Brien
Costs and medical care consequences associated with the diagnosis of peripheral arterial disease.
PharmacoEconomics 2005;23(7):733-42.
2005: Jaime Caro
Pharmacoeconomic analyses using discrete event simulation.
PharmacoEconomics 2005;23(4):323-32.
2004: Jaime Caro; Gregory W Albers
Optimizing oral anticoagulation in managed care.
The American journal of managed care 2004;10(14 Suppl):S474-7.
2004: Jaime Caro
An economic model of stroke in atrial fibrillation: the cost of suboptimal oral anticoagulation.
The American journal of managed care 2004;10(14 Suppl):S451-58; discussion S458-61.
2004: Jaime Caro; Khajak J Ishak; Krista F Huybrechts; Gabriel Raggio; Christel Naujoks
The impact of compliance with osteoporosis therapy on fracture rates in actual practice.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2004;15(12):1003-8.
2004: Jaime Caro; Denis Getsios; Ingrid Caro; Wendy S Klittich; Judith A O'Brien
Economic evaluation of therapeutic interventions to prevent Type 2 diabetes in Canada.
Diabetic medicine : a journal of the British Diabetic Association 2004;21(11):1229-36.
2004: Jaime Caro
An interview with J. Jaime Caro.
The American journal of managed care 2004;10(10 Suppl):S307-11.
2004: Jaime Caro; Khajak J Ishak; Kristen Migliaccio-Walle
Estimating survival for cost-effectiveness analyses: a case study in atherothrombosis.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2004;7(5):627-35.
2004: Jaime Caro; Khajak J Ishak; Ingrid Caro; Kristen Migliaccio-Walle; Wendy S Klittich
Comparing medications in a therapeutic area using an NNT model.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2004;7(5):585-94.
2004: Eric Desauziers; Luc Hessel; Michael D Decker; Jaime Caro; Johannes G Liese
Systematic review of the effects of pertussis vaccines in children.
Vaccine 2004;22(21-22):2681-4; author reply 2685.
2004: Denis Getsios; Jaime Caro; Khajak J Ishak; Wissam El-Hadi; Krista Payne
Canadian economic comparison of extended-release oxybutynin and immediate-release tolterodine in the treatment of overactive bladder.
Clinical therapeutics 2004;26(3):431-8.
2004: Denis Getsios; Jaime Caro; Khajak J Ishak; Wissam El-Hadi; Krista Payne; M O'connel; D Albrecht; W Feng; Dominique Dubois
Oxybutynin extended release and tolterodine immediate release : a health economic comparison.
Clinical drug investigation 2004;24(2):81-8.
2004: Denis Getsios; Ingrid Caro; Wissam El-Hadi; Jaime Caro
Assessing the economics of vaccination for Neisseria meningitidis in industrialized nations: a review and recommendations for further research.
International journal of technology assessment in health care 2004;20(3):280-8.
2004: Jaime Caro; Maribel Salas; Judith A O'Brien; Khajak J Ishak; Jennifer Sung; Gabriel Raggio
Modeling the efficiency of reaching a target intermediate end point: a case study in type 2 diabetes in the United States.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2004;7(1):13-21.
2003: Alexandra Ward; Jaime Caro; Denis Getsios; Khajak J Ishak; J O'Brien; R Bullock
Assessment of health economics in Alzheimer's disease (AHEAD): treatment with galantamine in the UK.
International journal of geriatric psychiatry 2003;18(8):740-7.
2003: Kristen Migliaccio-Walle; Denis Getsios; Jaime Caro; Khajak J Ishak; Judith A O'Brien; George Papadopoulos
Economic evaluation of galantamine in the treatment of mild to moderate Alzheimer's disease in the United States.
Clinical therapeutics 2003;25(6):1806-25.
2003: Judith A O'Brien; Amanda R Patrick; Jaime Caro
Cost of managing complications resulting from type 2 diabetes mellitus in Canada.
BMC health services research 2003;3(1):7.
2002: Jaime Caro; Alexandra Ward; Carey Levinton; Kimberly Robinson
The risk of diabetes during olanzapine use compared with risperidone use: a retrospective database analysis.
The Journal of clinical psychiatry 2002;63(12):1135-9.
2002: Jaime Caro; Karen Lee
Pharmacoutilization of antihypertensive drugs: a model of analysis.
Current hypertension reports 2002;4(6):419.
2002: Jaime Caro; Karen Lee
Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic.
Current hypertension reports 2002;4(6):418.
2002: Jaime Caro; Karen Lee
Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
Current hypertension reports 2002;4(6):417-8.
2002: Jaime Caro; Karen Lee
An economic evaluation of atenolol vs. captopril in patients with type 2 diabetes (UKPDS 24).
Current hypertension reports 2002;4(6):417.
2002: Alexandra Ward; Jaime Caro; Heather Kelley; Andrew Eggleston; William Molloy
Describing cognitive decline of patients at the mild or moderate stages of Alzheimer's disease using the Standardized MMSE.
International psychogeriatrics / IPA 2002;14(3):249-58.
2002: Denis Getsios; Jaime Caro; Graciela Caro; Phillipe De Wals; Barbara J Law; Yves Robert; Jean-Marie R Lance
Instituting a routine varicella vaccination program in Canada: an economic evaluation.
The Pediatric infectious disease journal 2002;21(6):542-7.
2002: Alexandra Ward; Jaime Caro; Traci Craig Green; Krista F Huybrechts; Alejandro Arana; Suzanne Wait; Androulla Eleftheriou
An international survey of patients with thalassemia major and their views about sustaining life-long desferrioxamine use.
BMC clinical pharmacology 2002;2():3.
2002: Jaime Caro; Alexandra J Ward; Judith A O'Brien
Lifetime costs of complications resulting from type 2 diabetes in the U.S.
Diabetes care 2002;25(3):476-81.
2002: Jaime Caro; Denis Getsios
Pharmacoeconomic evidence and considerations for triptan treatment of migraine.
Expert opinion on pharmacotherapy 2002;3(3):237-48.
2002: Wendy S Klittich; Jaime Caro
Lung cancer screening: will the controversy extend to its cost-effectiveness?
American journal of respiratory medicine : drugs, devices, and other interventions 2002;1(6):393-401.
2002: Maribel Salas; Jaime Caro
Are hypoglycaemia and other adverse effects similar among sulphonylureas?
Adverse drug reactions and toxicological reviews 2002;21(4):205-17.
2002: Krista A Payne; Krista F Huybrechts; Jaime Caro; Traci J Craig Green; Wendy S Klittich
Long term cost-of-illness in stroke: an international review.
PharmacoEconomics 2002;20(12):813-25.
2002: Jaime Caro; Maribel Salas; Alexandra Ward; Denis Getsios; Angelika Mehnert
Economic analysis of galantamine, a cholinesterase inhibitor, in the treatment of patients with mild to moderate Alzheimer's disease in the Netherlands.
Dementia and geriatric cognitive disorders 2002;14(2):84-9.
2002: Frances Garfield; Denis Getsios; Jaime Caro; Anders Wimo; Bengt Winblad
Assessment of Health Economics in Alzheimer's Disease (AHEAD): treatment with galantamine in Sweden.
PharmacoEconomics 2002;20(9):629-37.
2002: Judith A O'Brien; Jaime Caro
Direct medical cost of managing deep vein thrombosis according to the occurrence of complications.
PharmacoEconomics 2002;20(9):603-15.
2002: Jaime Caro; Denis Getsios; Ingrid Caro; Judith A O'Brien
Cost effectiveness of tinzaparin sodium versus unfractionated heparin in the treatment of proximal deep vein thrombosis.
PharmacoEconomics 2002;20(9):593-602.
2002: Jaime Caro; Alexandra Ward; Traci Craig Green; Krista F Huybrechts; Alejandro Arana; Suzanne Wait; Androulla Eleftheriou
Impact of thalassemia major on patients and their families.
Acta haematologica 2002;107(3):150-7.
2001: Denis Getsios; Jaime Caro; Graciela Caro; Khajak J Ishak
Assessment of health economics in Alzheimer's disease (AHEAD): galantamine treatment in Canada.
Neurology 2001;57(6):972-8.
2001: Jaime Caro; Denis Getsios; Kristen Migliaccio-Walle; Gabriel Raggio; Alexandra Ward
Assessment of health economics in Alzheimer's disease (AHEAD) based on need for full-time care.
Neurology 2001;57(6):964-71.
2001: J A O'Brien; Jaime Caro
Alzheimer's disease and other dementia in nursing homes: levels of management and cost.
International psychogeriatrics / IPA 2001;13(3):347-58.
2001: Jaime Caro; M Salas; Alexandra Ward
Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials.
Clinical therapeutics 2001;23(7):998-1017.
2001: Jaime Caro; K Payne
The value of industry-sponsored studies of initial antihypertensive therapies.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2001;164(13):1832-3.
2001: Jaime Caro; M Salas; A Ward; G Goss
Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review.
Cancer 2001;91(12):2214-21.
2001: Judith A O'Brien; Ingrid Caro; Denis Getsios; Jaime Caro
Diabetes in Canada: direct medical costs of major macrovascular complications.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2001;4(3):258-65.
2001: Jaime Caro; Denis Getsios; Gabriel Raggio; Graciela Caro; L Black
Treatment of migraine in Canada with naratriptan: a cost-effectiveness analysis.
Headache 2001;41(5):456-64.
2001: Graciela Caro; Denis Getsios; Jaime Caro; Gabriel Raggio; M Burrows; L Black
Sumatriptan: economic evidence for its use in the treatment of migraine, the Canadian comparative economic analysis.
Cephalalgia : an international journal of headache 2001;21(1):12-9.
2001: Jaime Caro; I Caro; J Caro; F Wouters; E F Juniper
Does electronic implementation of questionnaires used in asthma alter responses compared to paper implementation?
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2001;10(8):683-91.
2001: Jaime Caro; Judith A O'Brien; Kristen Migliaccio-Walle; Gabriel Raggio
Economic analysis of initial HIV treatment. Efavirenz- versus indinavir-containing triple therapy.
PharmacoEconomics 2001;19(1):95-104.
2001: Jaime Caro; Krista F Huybrechts; Heather Kelley
Predicting treatment costs after acute ischemic stroke on the basis of patient characteristics at presentation and early dysfunction.
Stroke; a journal of cerebral circulation 2001;32(1):100-6.
2000: Jaime Caro; Wendy S Klittich; G Strauss
Could chest X-ray screening for lung cancer be cost-effective?
Cancer 2000;89(11 Suppl):2502-5.
2000: Jaime Caro; Krista F Huybrechts; G De Backer; D De Bacquer; M C Closon
Are the WOSCOPS clinical and economic findings generalizable to other populations? A case study for Belgium. The WOSCOPS Economic Analysis Group. West of Scotland Coronary Prevention Study.
Acta cardiologica 2000;55(4):239-46.
2000: Cynthia Willey; Colleen A Redding; J Stafford; Frances Garfield; SM Geletko; T Flanigan; K Melbourne; Jennifer A Mitty; Jaime Caro
Stages of change for adherence with medication regimens for chronic disease: development and validation of a measure.
Clinical therapeutics 2000;22(7):858-71.
2000: Jaime Caro
Disease-simulation models and health care decisions.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2000;162(7):1001-2.
2000: Jaime Caro; Graciela Caro; Denis Getsios; Gabriel Raggio; M Burrows; L Black
The migraine ACE model: evaluating the impact on time lost and medical resource Use.
Headache 2000;40(4):282-91.
2000: M Salas; T Bubolz; Jaime Caro
Impact of physical functioning of health status on hospitalizations, physician visits, and costs in diabetic patients.
Archives of medical research 2000;31(2):223-7.
2000: Jaime Caro; Krista F Huybrechts; I Duchesne
Management patterns and costs of acute ischemic stroke : an international study. For the Stroke Economic Analysis Group.
Stroke; a journal of cerebral circulation 2000;31(3):582-90.
2000: Jaime Caro; K Payne
Real-world effectiveness of antihypertensive drugs.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2000;162(2):190-1.
2000: Jaime Caro
Introduction: practice guidelines. Helpful aids or paradigm shift?
International journal of technology assessment in health care 2000;16(4):957-8.
2000: Jaime Caro; Wendy S Klittich; Gabriel Raggio; P L Kavanagh; Judith A O'Brien; L A Shomphe; K M Flegel; C Copley-Merriman; C Sigler
Economic assessment of troglitazone as an adjunct to sulfonylurea therapy in the treatment of type 2 diabetes.
Clinical therapeutics 2000;22(1):116-27.
1999: Frances Garfield; Jaime Caro
Compliance and hypertension.
Current hypertension reports 1999;1(6):502-6.
1999: Jaime Caro
Current studies in pharmacoeconomics.
Current hypertension reports 1999;1(6):475-6.
1999: Jaime Caro; Kristen Migliaccio-Walle
Generalizing the results of clinical trials to actual practice: the example of clopidogrel therapy for the prevention of vascular events. CAPRA (CAPRIE Actual Practice Rates Analysis) Study Group. Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events.
The American journal of medicine 1999;107(6):568-72.
1999: Jaime Caro; Krista F Huybrechts
Stroke treatment economic model (STEM): predicting long-term costs from functional status.
Stroke; a journal of cerebral circulation 1999;30(12):2574-9.
1999: Jaime Caro; K M Flegel; M E Orejuela; Heather Kelley; JL Speckman; Kristen Migliaccio-Walle
Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1999;161(5):493-7.
1999: Frances Garfield; Jaime Caro
Postmarketing studies: benefits and risks.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 1999;2(4):295-307.
1999: Jaime Caro; JL Speckman; M Salas; Gabriel Raggio; J D Jackson
Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1999;160(1):41-6.
1999: Jaime Caro; M Salas; JL Speckman; Gabriel Raggio; J D Jackson
Persistence with treatment for hypertension in actual practice.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1999;160(1):31-7.
1998: Graciela Caro; Jaime Caro; J A O'Brien; S Anton; J Jackson
Migraine therapy: development and testing of a patient preference questionnaire.
Headache 1998;38(8):602-7.
1998: Jaime Caro; JL Speckman
Existing treatment strategies: does noncompliance make a difference?
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1998;16(7):S31-4.
1998: Judith A O'Brien; L A Shomphe; P L Kavanagh; Gabriel Raggio; Jaime Caro
Direct medical costs of complications resulting from type 2 diabetes in the U.S.
Diabetes care 1998;21(7):1122-8.
1997: Jaime Caro
Stepped care for hypertension: are the assumptions valid?
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1997;15(7):S35-9.
1996: Jaime Caro; Kristen Migliaccio-Walle; J A O'Brien
The cost of treating heart valve related complications.
The Journal of heart valve disease 1996;5(2):122-7.
1996: Kristen Migliaccio-Walle; W Klittich; J Banks; J A O'Brien; Jaime Caro
Bileaflet valve replacement: complications and costs.
Advances in therapy 1996;13(1):1-9.
1996: M Salas; Rolf Loertscher; Jaime Caro
Effect of cyclosporin weaning on glomerular filtration rate in renal transplantation.
Nephron 1996;74(2):309-12.
1995: Jeffrey Barkun; Jaime Caro; Alan N Barkun; evelinda trindade
Cost-effectiveness of laparoscopic and mini-cholecystectomy in a prospective randomized trial.
Surgical endoscopy 1995;9(11):1221-4.
1994: O S Miettinen; Jaime Caro
Foundations of medical diagnosis: what actually are the parameters involved in Bayes' theorem?
Statistics in medicine 1994;13(3):201-9; discussion 211-5.
1993: Jaime Caro; Patti Groome; K M Flegel
Atrial fibrillation and anticoagulation: from randomised trials to practice.
Lancet 1993;341(8857):1381-4.
1993: Jaime Caro; C B Johannes; S C Hartz; R Marrs; O S Miettinen
Re: "Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women".
American journal of epidemiology 1993;137(8):928-9.
1993: Jaime Caro; J A O'Brien; S C Hartz
Canadian National Breast Screening Study.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1993;148(6):876-7; author reply 880-3.
1992: Jaime Caro; evelinda trindade; M McGregor
The cost-effectiveness of replacing high-osmolality with low-osmolality contrast media.
AJR. American journal of roentgenology 1992;159(4):869-74.
1991: Jaime Caro; evelinda trindade; M McGregor
The risks of death and of severe nonfatal reactions with high- vs low-osmolality contrast media: a meta-analysis.
AJR. American journal of roentgenology 1991;156(4):825-32.
1989: O S Miettinen; Jaime Caro
Medical research on a complaint: orientation and priorities.
Annals of medicine 1989;21(5):399-401.
1989: O S Miettinen; Jaime Caro
Principles of nonexperimental assessment of excess risk, with special reference to adverse drug reactions.
Journal of clinical epidemiology 1989;42(4):325-31.